McCabe Cillian, Samali Afshin, O'Brien Timothy
Regenerative Medicine Institute, National Centre for Biomedical Engineering Sciences, National University of Ireland Galway, Galway, Ireland.
Diabetes Metab Res Rev. 2006 May-Jun;22(3):241-52. doi: 10.1002/dmrr.615.
Gene transfer to pancreatic islets may prove useful in preventing islet cell destruction and prolonging islet graft survival after transplantation in patients with type 1 diabetes mellitus (T1DM). Potentially, a host of therapeutically relevant transgenes may be incorporated into an appropriate gene delivery vehicle and used for islet modification. An increasing understanding of the molecular pathogenesis of immune-mediated beta cell death has served to highlight molecules which have become suitable candidates for promoting islet cell survival in the face of oxidative stress. This review aims to give an overview of some conventional gene transfer strategies aimed at promoting islet cell survival in the face of cytokine onslaught. These strategies target three aspects of islet cell physiology: redox status and antioxidant defence, anti-apoptotic gene expression and mediators of cytokine signal transduction pathways.
基因转移至胰岛可能被证明在预防1型糖尿病(T1DM)患者移植后胰岛细胞破坏及延长胰岛移植存活时间方面有用。潜在地,许多具有治疗相关性的转基因可被整合到合适的基因递送载体中,并用于胰岛修饰。对免疫介导的β细胞死亡分子发病机制的日益了解,凸显了一些在面对氧化应激时适合促进胰岛细胞存活的分子。本综述旨在概述一些旨在面对细胞因子攻击时促进胰岛细胞存活的传统基因转移策略。这些策略针对胰岛细胞生理学的三个方面:氧化还原状态与抗氧化防御、抗凋亡基因表达以及细胞因子信号转导途径的介质。